Core Insights - The article discusses the benefits of investing in exchange-traded funds (ETFs) that provide high dividends and stability, particularly for retirees and income-seeking investors [1][2]. Group 1: ETF Overview - Three recommended ETFs for retirees and income-seeking investors are Schwab U.S. Dividend Equity ETF, iShares Core Dividend Growth ETF, and ProShares S&P 500 Dividend Aristocrats ETF [3]. Group 2: Schwab U.S. Dividend Equity ETF - The Schwab U.S. Dividend Equity ETF yields 3.7%, significantly higher than the average S&P 500 stock yield of 1.2% [5]. - It has a low expense ratio of 0.06% and a beta of less than 0.7, indicating lower volatility [5][6]. - The fund has a diversified portfolio with only 8% exposure to tech stocks, while energy and consumer staples each account for around 19% [6]. Group 3: iShares Core Dividend Growth ETF - The iShares Core Dividend Growth ETF has a yield of approximately 2% and an expense ratio of 0.08% [8]. - It has a beta of 0.75 and has increased by 13% this year [8]. - The fund focuses on dividend growth stocks, with around 400 stocks in its portfolio, ensuring a diversified investment [9]. Group 4: ProShares S&P 500 Dividend Aristocrats ETF - The ProShares S&P 500 Dividend Aristocrats ETF offers just over 2% in dividends and has a beta of 0.77 [12]. - It has risen by around 4% this year and has an expense ratio of 0.35% [12]. - The ETF targets companies that have increased their dividends for at least 25 consecutive years, providing stability and lower volatility [13].

Core Viewpoint - Dividend ETFs are highlighted as a strong investment option, particularly in the context of potential market downturns, providing both income and stability against inflation [1][2]. Group 1: iShares 20+ Year Treasury Bond ETF (TLT) - TLT tracks the ICE U.S. Treasury 20+ Year Bond Index, offering exposure to long-dated U.S. government debt, which is expected to perform well during recessions [3]. - Long-term government bonds provide higher yields and are considered a safe investment, backed by the U.S. government [4]. - TLT currently offers a 3.97% monthly dividend yield, which is expected to remain stable, especially during market downturns when the Federal Reserve may cut interest rates [5]. - Historical performance shows TLT's price can significantly increase during recessions, as seen in late 2008 when it rose from $93 to over $122 [6]. Group 2: iShares Global Consumer Staples ETF (KXI) - KXI tracks the S&P Global 1200 Consumer Staples Index, providing exposure to global consumer staples stocks, which are known for their inelastic demand [7]. - This ETF is considered a good complement to bonds, offering both dividends and potential upside, with a low beta indicating resilience during market downturns [8]. - KXI yields 2.38% with an expense ratio of 0.39%, and it benefits from international stock exposure, which can appreciate if the U.S. dollar weakens [9]. Group 3: iShares US Pharmaceuticals ETF (IHE) - IHE tracks the Dow Jones U.S. Select Pharmaceuticals Index, focusing on large pharmaceutical companies that tend to perform well during economic downturns [11]. - The pharmaceutical sector is characterized by inelastic demand for medications, making it a stable investment choice [12]. - IHE has significant exposure to major companies like Eli Lilly and Johnson & Johnson, which together account for approximately 48% of the ETF's holdings, and it has shown strong year-to-date performance with a 26.7% increase [13].

Core Business and Dividend - Altria Group is recognized for its strong dividend history, boasting 56 consecutive years of dividend increases and a current yield of 7% as of December 8 [2][6] - The company has maintained a stable revenue stream despite declining smoking rates among American adults, which have dropped from approximately 42% in 1965 to just over 11% in 2022 [5][6] - Altria's pricing power has allowed it to offset declining volume, as consumers often continue purchasing preferred brands despite price increases [6][7] Financial Stability and Payout Ratios - Altria aims for a payout ratio of around 80% of its adjusted earnings per share (EPS), with recent payout ratios ranging from 70.8% to 82.9% [10] - The adjusted EPS provides a clearer picture of the company's operational earnings, indicating that the dividend is not in immediate jeopardy [9][10] - The stock is currently trading at about 10.7 times projected earnings for the next 12 months, suggesting it is undervalued compared to historical standards [11] Investment Perspective - While Altria may not offer high revenue growth, it is considered a solid option for investors seeking above-average dividend income [12] - The company is viewed as a bargain for those willing to invest despite concerns regarding the traditional cigarette business [11] - Altria's long-standing presence in the market and consistent dividend payments make it an attractive choice for income-focused investors [2][12]

Group 1 - Simon Property Group (SPG) is a REIT that has been viewed positively in recent years due to its undervaluation [1] - SPG has outperformed the market since the last coverage [1] - The focus is on dividend investing in quality blue-chip stocks, BDCs, and REITs to supplement retirement income [1] Group 2 - The article expresses the author's personal opinions and does not constitute financial advice [2] - There are no current stock or derivative positions in any mentioned companies [2] - The author is not receiving compensation for the article beyond Seeking Alpha [2]

Core Insights - The article highlights the difficulty in finding attractively priced opportunities in equity markets as market indices approach all-time highs while income-focused funds are facing challenges due to higher interest rates [1] Group 1: Market Conditions - Market indices are hovering near all-time highs, making it challenging to identify attractive investment opportunities [1] - Income-focused funds are particularly affected by the current environment of higher interest rates [1] Group 2: Investment Strategy - The article discusses a hybrid investment strategy that combines classic dividend growth stocks with Business Development Companies, REITs, and Closed End Funds to enhance investment income while achieving total returns comparable to traditional index funds like the S&P [1]

Company Overview - Griffon Corporation has a market capitalization of $3.42 billion and operates within the industrial sector, specifically in the building products industry [3]. Ratings and Analyst Opinions - The Seeking Alpha Quant rating system currently assigns a Sell rating to Griffon Corporation's stock [2]. - In contrast, Seeking Alpha Analysts have an aggregate Buy rating based on coverage from two analysts in the last 90 days [2]. - Wall Street analysts have a Strong Buy rating, with seven analysts providing coverage in the last 90 days [2]. Valuation Metrics - The stock has a Valuation grade of D+, with a PEG to non-GAAP forward ratio of 0.89, significantly lower than the sector average of 1.80, indicating it is severely undervalued [4]. - The price-to-cash flow forward ratio stands at 9.11, compared to the sector average of 16.12, reflecting a 43% discount [4]. Growth and Profitability - The Growth grade is currently C-, with year-over-year revenue growth down nearly 4%, while the sector shows an increase of almost 4% [5]. - Profitability is rated B, with an EBITDA margin of 20.57%, which is higher than the sector average of 14.48% and above its five-year average of 15.36% [5]. Momentum and Revisions - The Momentum grade is C, with a one-year price performance down 8.44%, while the sector is up by 86 basis points [6]. - The Revisions grade is F, with zero up revisions and six down revisions for earnings per share over the last three months, and three up revisions and four down revisions for revenue [7]. Dividend Information - Griffon Corporation pays a dividend with a yield of 1.19% and a five-year growth rate of 20.03% [8]. - The dividend safety grade is B+, with an A for dividend growth, a B+ for yield, and a B for consistency, having paid dividends for 14 years [8].

Core Insights - Generating a regular stream of income through dividend-paying stocks is essential for retirement planning [3] - Exchange-traded funds (ETFs) provide a diversified approach to investing in dividend stocks, managed by professionals [4] Group 1: Schwab U.S. Dividend Equity ETF (SCHD) - SCHD has a high yield of approximately 3.88% and invests in 103 high-quality, large-cap companies from the Dow Jones U.S. Dividend 100 Index [6] - The fund focuses on sectors such as energy, consumer staples, and healthcare, which are considered defensive and resilient during economic downturns [6] - SCHD has a low expense ratio of 0.06%, net assets of $71.55 billion, and a five-year return of about 30% [7] Group 2: Schwab International Dividend Equity ETF (SCHY) - SCHY offers global diversification by investing in high-yielding stocks from companies outside the United States, with a yield of around 4% [8][9]

Core Insights - Generating a steady income through dividend-paying stocks is a key investment strategy, with many investors opting for dividend-paying ETFs for diversification and professional management [1][2] Dividend ETFs Overview - Dividend ETFs vary in yield, with some generating around 2% to 3%, while others exceed 5% [2] - Key dividend ETFs include: - **iShares Preferred and Income Securities ETF (PFF)**: Yield of approximately 6.46%, investing in financial, industrial, and utilities sectors, with top holdings including Boeing, Wells Fargo, and Citigroup. Net assets are $14.65 billion and an expense ratio of 0.45% [3][4] - **Global X SuperDividend U.S. ETF (DIV)**: Yield of about 6.70%, focusing on the 50 highest dividend-paying companies in the U.S. with low volatility. It has maintained monthly distributions for 12 years, net assets of around $653.32 million, and an expense ratio of 0.45% [5][6] - **iShares Emerging Markets Dividend ETF (DVYE)**: Yield of 9.59%, investing in 100 companies across emerging markets, with net assets of about $942.72 million and an expense ratio of 0.50% [7][8] - **Invesco KBW Premium Yield Equity REIT ETF (KBWY)**: Yield of around 9.50%, investing in small and mid-cap equity REITs. It has net assets of about $252.07 million and an expense ratio of 0.35%, but has delivered a negative 1-year return of approximately 22.11% [9][10] - **Invesco S&P SmallCap High Dividend Low Volatility ETF (XSHD)**: Yield of around 6.70%, focusing on small-cap companies with high dividend yields and low volatility. It has net assets of $74.1 million and an expense ratio of 0.30% [11][12] Considerations for Choosing Dividend ETFs - Yield is not the only factor to consider; past performance, fund holdings, and expense ratios are also important [13][14]

Core Viewpoint - Build-A-Bear Workshop (BBW) has shown strong performance compared to typical growth stocks, despite not being a conventional dividend stock, and recently reported mixed Q3 earnings results [1]. Financial Performance - BBW reported its Q3 earnings with mixed results, indicating variability in performance metrics [1]. Investment Perspective - The company has been viewed positively since early 2024, suggesting a bullish outlook among analysts and investors [1].

Core Viewpoint - The Schwab U.S. Dividend Equity ETF (SCHD) is a favored investment option for retirees, focusing on dividend-paying U.S. stocks with strong financial metrics and a history of consistent dividend payments [1]. Dividend Yield and Top Holdings - SCHD currently offers a yield of 3.9%, surpassing most other stocks and the S&P 500 [2]. - The top five holdings contributing to this yield include: - Merck (MRK): 4.71% yield, contributing 3.51% to ETF yield - Cisco Systems (CSCO): 4.67% yield, contributing 2.06% to ETF yield - Amgen (AMGN): 4.54% yield, contributing 3.03% to ETF yield - Bristol Myers (BMY): 4.24% yield, contributing 4.9% to ETF yield - AbbVie (ABBV): 4.22% yield, contributing 3.1% to ETF yield [2]. Dividend Safety Analysis - The dividend safety varies among the top holdings, with Merck showing a conservative payout ratio of 43% and a history of uninterrupted payments for over 26 years [4]. - Cisco's payout ratio is 63%, while Amgen's is 73% and Bristol-Myers is 85%, indicating increasing risk as the payout ratios rise [5]. - AbbVie presents the highest concern with a 501% payout ratio based on trailing earnings, but its operating cash flow of $18.8 billion in 2024 allows for a more manageable 58.6% cash flow payout ratio [6][7].